These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 34480749)

  • 41. Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.
    Kahan M; Srivastava A; Spithoff S; Bromley L
    Can Fam Physician; 2014 Dec; 60(12):1083-90. PubMed ID: 25500598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoids in the treatment of rheumatic diseases: Pros and cons.
    Sarzi-Puttini P; Ablin J; Trabelsi A; Fitzcharles MA; Marotto D; Häuser W
    Autoimmun Rev; 2019 Dec; 18(12):102409. PubMed ID: 31648042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence.
    Babalonis S; Walsh SL
    Eur Neuropsychopharmacol; 2020 Jul; 36():206-216. PubMed ID: 32273144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
    Cooper ZD; Abrams DI
    Am J Drug Alcohol Abuse; 2019; 45(6):580-595. PubMed ID: 31687845
    [No Abstract]   [Full Text] [Related]  

  • 45. Cannabis and cannabinoids.
    Med Lett Drugs Ther; 2016 Aug; 58(1500):97-8. PubMed ID: 27466748
    [No Abstract]   [Full Text] [Related]  

  • 46. Medical Cannabis for Headache Pain: a Primer for Clinicians.
    Duarte RA; Dahmer S; Sanguinetti SY; Forde G; Duarte DP; Kobak LF
    Curr Pain Headache Rep; 2021 Oct; 25(10):64. PubMed ID: 34628531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice.
    Landa L; Jurica J; Sliva J; Pechackova M; Demlova R
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Mar; 162(1):18-25. PubMed ID: 29560966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
    Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
    JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Not Available].
    Briner A; Schneider T
    Ther Umsch; 2017; 74(5):261-266. PubMed ID: 29083285
    [No Abstract]   [Full Text] [Related]  

  • 50. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Focus on cannabinoids and synthetic cannabinoids.
    Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
    Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequelae of Cannabis as Medicine.
    Finn K
    Pain Med; 2015 Jul; 16(7):1447-9. PubMed ID: 26108137
    [No Abstract]   [Full Text] [Related]  

  • 53. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.
    Aviram J; Lewitus GM; Pud D; Procaccia S; Berman P; Yellin B; Vysotski Y; Hazan O; Eisenberg E; Meiri D
    Pharmacol Res; 2021 Jul; 169():105651. PubMed ID: 34000362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marijuana, Lower Urinary Tract Symptoms, and Pain in the Urologic Patient.
    Pham MN; Hudnall MT; Nadler RB
    Urology; 2020 May; 139():8-13. PubMed ID: 32027882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals With Chronic Pain.
    Boehnke KF; Scott JR; Litinas E; Sisley S; Williams DA; Clauw DJ
    J Pain; 2020; 21(5-6):570-581. PubMed ID: 31560957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia.
    Berger AA; Keefe J; Winnick A; Gilbert E; Eskander JP; Yazdi C; Kaye AD; Viswanath O; Urits I
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):617-631. PubMed ID: 33004171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using Therapeutic Drug Monitoring and Pharmacovigilance to Overcome Some of the Challenges of Developing Medicinal Cannabis from Botanical Origins.
    Dryburgh LM; Martin JH
    Ther Drug Monit; 2020 Feb; 42(1):98-101. PubMed ID: 31479044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
    Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L
    Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.